217 related articles for article (PubMed ID: 26114485)
1. Associations Between Topical Ophthalmic Corticosteroids and Central Serous Chorioretinopathy: A Taiwanese Population-Based Study.
Chang YS; Weng SF; Chang C; Wang JJ; Wang JY; Jan RL
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4083-9. PubMed ID: 26114485
[TBL] [Abstract][Full Text] [Related]
2. Temporal Association between Topical Ophthalmic Corticosteroid and the Risk of Central Serous Chorioretinopathy.
Chang YS; Weng SF; Wang JJ; Jan RL
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33348672
[TBL] [Abstract][Full Text] [Related]
3. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan.
Tsai DC; Chen SJ; Huang CC; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Chen TJ; Leu HB
Retina; 2014 Sep; 34(9):1867-74. PubMed ID: 24743638
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of erectile dysfunction among males with central serous chorioretinopathy -- a retrospective cohort study.
Tsai DC; Huang CC; Chen SJ; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Leu HB
Acta Ophthalmol; 2013 Nov; 91(7):666-71. PubMed ID: 22998678
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: results of a population-based cohort study.
Chen SN; Chen YC; Lian I
Br J Ophthalmol; 2014 Jan; 98(1):110-4. PubMed ID: 24169652
[TBL] [Abstract][Full Text] [Related]
6. Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease.
Ricketti PA; Unkle DW; Cleri DJ; Prenner JL; Coluccielo M; Ricketti AJ
Allergy Asthma Proc; 2015; 36(2):123-9. PubMed ID: 25715240
[TBL] [Abstract][Full Text] [Related]
7. Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study.
Tsai DC; Huang CC; Chen SJ; Chou P; Chung CM; Chan WL; Huang PH; Chen TJ; Lin SJ; Chen JW; Leu HB
Br J Ophthalmol; 2012 Dec; 96(12):1484-8. PubMed ID: 22976583
[TBL] [Abstract][Full Text] [Related]
8. RISK OF RHEGMATOGENOUS RETINAL DETACHMENT WITH CENTRAL SEROUS CHORIORETINOPATHY.
Chang YS; Chang C; Weng SF; Wang JJ; Jan RL
Retina; 2016 Aug; 36(8):1446-53. PubMed ID: 26716956
[TBL] [Abstract][Full Text] [Related]
9. RISK OF RETINAL VEIN OCCLUSION WITH CENTRAL SEROUS CHORIORETINOPATHY.
Chang YS; Chang C; Weng SF; Wang JJ; Jan RL
Retina; 2016 Apr; 36(4):798-804. PubMed ID: 26441266
[TBL] [Abstract][Full Text] [Related]
10. Central serous chorioretinopathy, corticosteroids, and uveitis.
Khairallah M; Kahloun R; Tugal-Tutkun I
Ocul Immunol Inflamm; 2012 Apr; 20(2):76-85. PubMed ID: 22409559
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.
Tsai DC; Chen SJ; Huang CC; Chou P; Chung CM; Huang PH; Lin SJ; Chen JW; Chen TJ; Leu HB; Chan WL
PLoS One; 2013; 8(6):e66858. PubMed ID: 23826160
[TBL] [Abstract][Full Text] [Related]
12. Increased incidence of peptic ulcer disease in central serous chorioretinopathy patients: a population-based retrospective cohort study.
Chen SN; Lian I; Chen YC; Ho JD
Retina; 2015 Feb; 35(2):231-7. PubMed ID: 25099218
[TBL] [Abstract][Full Text] [Related]
13. Unintentional secondary exogenous corticosteroid exposure and central serous chorioretinopathy.
Thinda S; Lam K; Park SS
Eye (Lond); 2015 Apr; 29(4):577-9. PubMed ID: 25592121
[TBL] [Abstract][Full Text] [Related]
14. Increased risk for central serous chorioretinopathy in nephrotic syndrome patients: A population-based cohort study.
Lee LC; Wu TJ; Huang KH; Chen YH; Chen JT; Chung CH; Chien WC; Chen CL
J Chin Med Assoc; 2021 Nov; 84(11):1060-1069. PubMed ID: 34320516
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the relationship between central serous chorioretinopathy and liver cirrhosis: A nationwide, population-based study.
Hsu CC; Chen YH; Huang KH; Chen J; Chung CH; Liang CM; Chien WC; Chen CL
J Chin Med Assoc; 2021 Jun; 84(6):655-663. PubMed ID: 33871388
[TBL] [Abstract][Full Text] [Related]
16. Association of Corticosteroid Use With Incidence of Central Serous Chorioretinopathy in South Korea.
Rim TH; Kim HS; Kwak J; Lee JS; Kim DW; Kim SS
JAMA Ophthalmol; 2018 Oct; 136(10):1164-1169. PubMed ID: 30098167
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
Sogutlu Sari E; Yazici A; Eser B; Erol MK; Kilic A; Ermis SS; Koytak A; Akşit H; Yakut T
Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of central serous chorioretinopathy following end-stage renal disease: A nationwide population-based study.
Chang YS; Weng SF; Wang JJ; Jan RL
Medicine (Baltimore); 2019 Mar; 98(11):e14859. PubMed ID: 30882685
[TBL] [Abstract][Full Text] [Related]
19. Central serous chorioretinopathy following kidney transplantation.
Farzan K; Rezaei L; Ghanbari H; Dehghani A
Saudi J Kidney Dis Transpl; 2014 May; 25(3):615-20. PubMed ID: 24821161
[TBL] [Abstract][Full Text] [Related]
20. Relationship between Obstructive Sleep Apnea and Central Serous Chorioretinopathy: A Health Insurance Database Study.
Lee CY; Yeung L; Kuan Jen C; Sun MH; Sun CC
Ophthalmic Epidemiol; 2022 Jun; 29(3):302-309. PubMed ID: 34016006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
